Quote:
Originally Posted by jfman
Far from - at a global level as you have correctly noted for the vast majority in the pandemic it’s the only vaccine they will ever see before 2023.
However that added value doesn’t necessarily equate to it providing the maximum level of protection here - I suspect something reflected in the fact that while some countries are using it for a booster dose we are not.
|
mRNA vaccines have proven just how astonishingly good they are, both in terms of speed of development and efficacy. Advanced economies with the money to buy them and the infrastructure to store and distribute them can and should use them. However, viral vector vaccines are much, much cheaper to produce and distribute and the real-world efficacy of Oxford/AZ is so good it is going to have a role in the world programme for a very long time to come.
I’m glad to see you acknowledge this because there have been times over the last year when you have seemed distinctly peeved at its success and have questioned its use within the UK at all, despite the very obvious and immediate need.